Director, Cancer Prevention & Early Detection Center (Interception®)

Background

Gustave Roussy employs more than 4,000 staff, including 1,600 dedicated to research, and hosts 43 research teams. The institute enrols approximately 7,000 patients annually in clinical studies. The Interception® programme, launched in 2021, has expanded to 14 centres across France, with further expansion planned (23 centers already planned). It integrates clinical activities for high-risk individuals with translational research programmes focusing on premalignant conditions and molecular risk factors. The programme is supported by philanthropic funding and the PRISM Precision Medicine Institute.

The Position

The Director will define and implement the strategic vision of Interception®. Responsibilities include leading multidisciplinary clinical teams, developing a portfolio of innovative clinical trials in cancer prevention, early detection and interception, and overseeing translational research programmes. The post-holder will coordinate national and international collaborations and contribute to the institutional leadership of Gustave Roussy.

Candidate Profile

Applicants must hold an MD and PhD, with at least 10 years of experience, in oncology, cancer prevention or related fields. The successful candidate will demonstrate a strong track record in leading clinical and research programmes, securing competitive funding, and mentoring junior investigators. International experience and the ability to work within global research networks are essential.

Resources

The position is supported by a €3M start-up package, in addition to existing institutional and PRISM funding (€3M). Dedicated laboratory space (100 m²) and access to a highly integrated clinical and research ecosystem are provided.

Application

Applications should include a curriculum vitae and a statement of research and leadership vision. Candidates will be shortlisted for interviews and site visits. Applications should be sent to: cecile.tableau@gustaveroussy.fr